Reactogenicity and safety of AS03B-adjuvanted H5N1 influenza vaccine in children: an open-label, one-way, crossover trial
, , , , , oraz
21 mar 2018
O artykule
Kategoria artykułu: Brief communication
Data publikacji: 21 mar 2018
Zakres stron: 359 - 364
DOI: https://doi.org/10.1515/abm-2018-0008
Słowa kluczowe
© 2017 Patricia Izurieta, Pope Kosalaraksa, Louise Frenette, Mamadou Dramé, Bruce L. Innis, David W Vaughn, Anne Schuind
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Izurieta, Patricia
GSKWavre, Belgium
Kosalaraksa, Pope
Department of Pediatrics, Khon Kaen UniversityKhon Kaen, Thailand
Frenette, Louise
Q&T ResearchSherbrooke, Canada
Dramé, Mamadou
GSKKing of Prussia, USA
Innis, Bruce L.
Vaccines Discovery and Development, GSKKing of Prussia, USA
Vaughn, David W
Vaccines Discovery and Development, GSKKing of Prussia, USA
Schuind, Anne
Vaccines Discovery and Development, GSKKing of Prussia, USA